Satellos Bioscience Files 6-K Report
Ticker: MSLE · Form: 6-K · Filed: Apr 9, 2026 · CIK: 0001421642
| Field | Detail |
|---|---|
| Company | Satellos Bioscience INC. (MSLE) |
| Form Type | 6-K |
| Filed Date | Apr 9, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, foreign-issuer, regulatory
TL;DR
Satellos Bioscience filed a 6-K on 4/9/26, check press release for details.
AI Summary
Satellos Bioscience Inc. filed a Form 6-K on April 9, 2026, reporting information as a foreign issuer. The filing includes a press release as an exhibit, but no specific financial figures or operational updates are detailed in the provided metadata.
Why It Matters
This filing indicates Satellos Bioscience Inc. is providing updated information to the SEC, which could be relevant for investors monitoring the company's regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — The filing is a routine disclosure report (6-K) with no immediate indication of significant financial or operational changes.
Key Players & Entities
- Satellos Bioscience Inc. (company) — Filer
- 0001421642 (company) — CIK Number
- 2026-04-09 (date) — Filing Date
- 2834 (company) — SIC Code
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
When was this filing accepted by the SEC?
The filing was accepted on 2026-04-09 at 07:00:08.
What is the CIK number for Satellos Bioscience Inc.?
The CIK number for Satellos Bioscience Inc. is 0001421642.
What is the SIC code listed for Satellos Bioscience Inc.?
The SIC code listed is 2834, which corresponds to Pharmaceutical Preparations.
What documents are included in this filing?
The filing includes a Form 6-K document and a press release (EX-99.1).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 9, 2026 regarding Satellos Bioscience Inc. (MSLE).